Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 4.4 M18.75 M — Research & development 27.09 M64.62 M — Operating income -31.5 M-83.38 M — Non-Operating Income, Total 2.08 M3.83 M — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses 1.55 M2.47 M — Unusual income/expense 531 K1.36 M — Pretax income -29.42 M-79.55 M — Equity in earnings —— — Taxes —0 — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations -29.42 M-79.55 M — Discontinued operations —— — Net income -29.42 M-79.55 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders -29.42 M-79.55 M — Basic earnings per share (Basic EPS) -37.1887.14 — Diluted earnings per share (Diluted EPS) -37.18-9.16 — Average basic shares outstanding 791.13 K8.68 M — Diluted shares outstanding 791.13 K8.68 M — EBITDA —— — EBIT —— — Cost of revenue —— — Other cost of goods sold —— — Depreciation & amortization (cash flow) 100 K140 K —